Jeffrey Poulton
Directeur Financier/CFO chez ALNYLAM PHARMACEUTICALS, INC.
Fortune : 4 M $ au 30/04/2024
Profil
M. Jeffrey V. Poulton est un directeur indépendant chez Homology Medicines, Inc. et un directeur financier et comptable chez Alnylam Pharmaceuticals, Inc. Il est membre du conseil d'administration de Homology Medicines, Inc, Alnylam UK Ltd et EIP Pharma, Inc. M. Poulton a été précédemment employé comme directeur financier par Indigo Agriculture, Inc. et comme directeur financier et directeur exécutif par Shire Plc. Il a obtenu son diplôme de premier cycle à l'université de Duke et un MBA à la Kelley School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 27 276 ( 0,02% ) | 4 M $ | 30/04/2024 | |
CERVOMED INC.
0,20% | 29/04/2024 | 16 444 ( 0,20% ) | 410 936 $ | 30/04/2024 |
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Jeffrey Poulton
| Sociétés | Poste | Début |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Financier/CFO | 13/08/2019 |
| CERVOMED INC. | Directeur/Membre du Conseil | 16/08/2023 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The company is based in Maidenhead, UK. | Directeur/Membre du Conseil | 13/08/2019 |
Anciens postes connus de Jeffrey Poulton
| Sociétés | Poste | Fin |
|---|---|---|
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Directeur Financier/CFO | 01/04/2019 |
| SHIRE | Directeur Financier/CFO | 31/12/2017 |
| Q32 BIO INC. | Directeur/Membre du Conseil | - |
Formation de Jeffrey Poulton
| Duke University | Undergraduate Degree |
| Kelley School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| CERVOMED INC. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Founded in 2002, Alnylam UK Ltd. is a subsidiary of Alnylam Pharmaceuticals, Inc. that develops biotechnology products. The company is based in Maidenhead, UK. | Health Technology |
Indigo Ag, Inc.
Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Health Technology |